Status:
NOT_YET_RECRUITING
Retrospective Clinical Validation of HepatoPredict
Lead Sponsor:
Ophiomics
Collaborating Sponsors:
University Hospital Birmingham NHS Foundation Trust
Conditions:
Hepato Cellular Carcinoma (HCC)
Liver Resection
Eligibility:
All Genders
18+ years
Brief Summary
HepatoPredict is an innovative prognostic tool to support hepatologists, hepatobiliary surgeons and multidisciplinary teams in deciding on the best therapeutical approach for a patient with Hepatocell...
Detailed Description
Liver cancer remains a global health challenge with growing incidence worldwide. Hepatocellular carcinoma (HCC) is the most common liver cancer, accounting for \~90% of the cases and for 75% of the de...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old.
- Patients with HCC that underwent transplantation, with at least 5 years follow-up.
- Patients with HCC that underwent surgical resection, with at least 5 years follow-up.
- Completed informed consent process (for patient candidates that are still alive).
Exclusion
- Age \< 18 years old.
- Other non-HCC liver cancers patients.
- Patients with tumor extra-hepatic spread at diagnosis.
Key Trial Info
Start Date :
March 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06894524
Start Date
March 1 2025
End Date
April 30 2026
Last Update
March 25 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.